Zhang J. et al. [10] demonstrated that Radiomics alone and combination models significantly performed better than clinical models alone in discriminating epidermal growth factor receptor (EGFR) mutation status in NSCLC. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.